Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Lung Cancer
New lung cancer study findings have been reported from K. Dimakou et al
July 13th, 2009
"Adenosine deaminase (ADA) has been widely used for the diagnosis of tuberculous pleural effusion. Two isoenzymes have been described, ADA(1) and ADA(2)," researchers in Athens, Greece report. "To evaluate the diagnostic value of sputum ADA, ADA, and ADA(2) activity in pulmonary tuberculosis (TB). We measured total ADA, ADA(1) and ADA(2) activity in the sputum of 27 patients with pulmonary TB (11 had a negative Ziehl-Neelsen stain for acid-fast bacilli [AFB]). Nineteen patients with lung cancer were used as controls. Sputum total ADA activity was significantly higher in TB than in lung cancer patients (median 18 U/l [range 3-70] vs. 6 U/l [2-16]; P< 0.001). Sputum...
Source: Biotech Business Week (2009-07-13)
|
